Our goal is to aid in better understanding of Cannabis and Cannabis Extracts production in order to provide better consistency, quality and better patient outcomes. We advocate for full retroactive decriminalization of Cannabis and Cannabis Extracts and for Regulated and Taxed Repsonsible Adult Use of these products.
Canaveral Laboratories LLC in Melbourne Florida is a well equipped industrial laboratory built out with instrumentation to do Cannabis and Cannabis Extract Testing. We are a Florida owned and operated business and are not a franchise or clinical/environmental lab.
We are applying for ISO:17025 accreditation with A2LA. ISO is a non-governemental agency that sets the standards for quality in most all types of manufacturing. We developed our ISO quality system starting the day we opened our doors. ISO accreditation means "Document what you do, and do what your Document". An independent Auditor checks our documents for completeness and witnesses that we do we we documented in our Standard Operation Procedures (SOP).
Canaveral Laboratories offers the following tests for Cannabis and Cannabis Extracts at this time:
1. Potency - Test reports concentrations of 11 Cannabinoids (CBD, CBDA, CBC, CBN, CBG, CBGA, CBDV, d9-THC, d8-THC, THCV, THCA) using a HPLC Liquid Chromatograph and a Validated Test Method.
2. Terpenes - Test reports concentrations of up to 21 Terpenes (includuing Pinenes, Terpinene, Caryolphyllene, Cymene, Linalool, Camphene etc...)
3. Residual Solvents - Test reports Residual Solvents per the California List (1,2-Dichloroethane,Acetone,Acetonitrile,Benzene,Chloroform, Ethanol,Ethyl Acetate,Ether,n-Heptane,n-Hexane,2-Propanol,Methanol,Methylene chloride, n-Pentane,Trichloroethene, Toluene,m-Xylene,o-Xylene,p-Xylene
4. Consulting - Quality Control, Processing, Extraction, Labeling, Compliance
A. Microbial Testing
B. Mycotoxin Testing
C. Pesticides Testing
D. Heavy Metals Testing
E. Sampling and Water Activity Testing
F. Shelf Stability Testing
The nature of the medical cannabis industry and the cannabis industry in general is strongly tied to a moral dilemma and to a legal dilemma. The moral dilemma is something that can be discussed and debated, like moral issues of the same type. The legal dilemma, not so.
With the gradual change in global social acceptance of cannabis, and the heroic efforts of a few daring pioneers, the understanding of the medical value of cannabis is becoming more understood. The medical value is unique, but largely undocumented as research has been outside of federal law. This legal issue, and its affect on production and distribution has created products of a wide diversity of qualities, dosages of active ingredients and that provide uncertain and uneven patient outcomes. Rapid expansion of this industry has led to production challenges and products contaminated with mycotoxins and pesticides. Chemical enhancers have also been found, such as synthetic Cannabis alkaloids.
The development and passage of the Federal Farm Bills and the establishment of State Hemp Programs has brought an enormous expansion of the Hemp and Hemp Extracts (such as CBD isolate) marketplace. Not all States have defined a difference between Hemp and "Marijuana" creating a gap between State and Federal Law.
In Florida, the July 2019 passage of the Senate Bill 1020, has advanced the Hemp and Hemp Extract industry and creates regulatory requirements that will need to be addressed. Canaveral Laboratories is working to provide services to meet these new requirements.